Biper Therapeutics
BiPER Therapeutics is developing a first-in-class pipeline of therapeutics overstressing cells to cure patients. The company’s lead compound, BPR001, is a first-in-class small molecule therapeutic targeting BiP, an oncogenic protein shown to have a critical role in cancer
7-day free trial · no credit card
Verified contacts
5
available on Kipplo
LinkedIn employees
10
1 to 10 range
Open roles
—
no listings
Distinct roles
4
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 5 verified contacts at Biper Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
5 contacts with verified email or phone · masked until revealed.
- NT
Nedra Tekaya
Chef De Projet R & d Etude Préclinique · Research & Development
EmailPhone - FB
Fanny Bonnard
Technicien Recherche Et Développement · Research & Development
EmailPhone - AN
Albane Neckebroeck
É () · Other
EmailPhone - MC
Mehdi Chelbi
É () · Other
EmailPhone - SR
Stéphane Rocchi
Co-founder Biper Therapeutics · Other
EmailPhone
Showing 5 of 5 verified contacts
Top roles at Biper Therapeutics
4 distinct titles indexed · top 4 shown.
- 2é ()
- 1chef de projet r & d etude préclinique
- 1co-founder biper therapeutics
- 1technicien recherche et développement
Sign up to unlock all 5 contacts at Biper Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 5 verified contacts at Biper Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.